This report for clinicians explains approaches to providing integrated care to older adults living with substance use disorder and mental illness. It highlights the importance of assessing patients for cognitive deficits and adapting behavioral interventions to help improve treatment outcomes.
Dashboard: Filter Bricks
Main page content
This publication provides an overview of federal disclosure laws affecting private-sector, employer sponsored group health plans and health insurers. This document is not a comprehensive description of these laws and should not be considered legal advice.
This manual offers guidance on how to engage youth during government-sponsored events and meetings. It includes resources to support youth services, youth development, youth leadership, civic engagement, and youth organizing.
This report offers best practices for implementing the Mental Health Parity and Addiction Equity Act of 2008. It covers processes for implementing parity and collaborating with other organizations. The report also discusses tools for understanding and monitoring compliance.
This resource describes the Mental Health Parity and Addiction Equity Act of 2008 for people with employer-sponsored health plans who need treatment for mental and/or substance use disorders. It discusses how to file a claim, the denial of a claim and the appeals process.
This advisory defines attention deficit hyperactivity disorder in adults, and explains interactions with substance use disorders.
This pocket guide is designed as a quick reference for information about medication-assisted treatment for alcohol use disorder. It offers a checklist for prescribing medications to patients and provides a list of approved medications for treatment.
This manual provides guidance on the use of medication-assisted treatment for alcohol use misuse. It summarizes approved medications, screening and assessment, treatment planning, and patient monitoring.
This guide highlights the use of medication-assisted treatment (MAT) for opioid use disorder in drug courts. It reviews effective medications, including methadone, buprenorphine, and naltrexone. The guide also provides strategies to increase the use of MAT in drug court programs.
This report summarizes the clinical and cost effectiveness of crisis services. It also presents case studies of approaches states are using to coordinate, consolidate, and blend funding sources to provide robust crisis services.
Displaying 21 - 30 out of 57